Navigation Links
CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Date:6/17/2009

treatment of melanoma and for the treatment of metastatic breast cancer, and in a Phase I trial to evaluate the safety and activity of alternate dosing schedules.

About Breast Cancer

Breast cancer is the most common cancer in women and a leading cause of death in the United States. According to the American Cancer Society, more than 180,000 women will be diagnosed with invasive breast cancer in 2009 with more than 40,000 deaths attributed to this disease. Despite recent advances in therapy, the median survival of patients with metastatic breast cancer is 2 to 3 years, while patients with "triple-negative" or "basal-like" breast cancer have limited treatment options and poorer outcomes. Therefore, a significant unmet need remains for novel therapeutic approaches for patients with locally advanced and metastatic breast cancer who have failed other therapies.

About CuraGenCuraGen Corporation (Nasdaq: CRGN) is a clinical-stage biopharmaceutical company developing promising approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.

Forward-Looking Statements

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to CuraGen's development program for CR011-vcMMAE, including CuraGen's ability to advance CR011-vcMMAE through Phase II clinical trials for melanoma and metastatic breast cancer, to explore additional doses and schedules of this antibody-drug conjugate, and to explore the potential of CR011-vcMMAE in a patient population in need of new therapies may c
'/>"/>

SOURCE CuraGen Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Updates CR011-vcMMAE Data at ASCO
2. CuraGen to Present CR011-vcMMAE Data at ASCO
3. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
6. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
7. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
8. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. CuraGen Advances CR011-vcMMAE into Phase II
11. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Mass.,Nov.24/PRNewswire-FirstCall/--EchoTherapeut...itsneedle-freeSymphony(TM)tCGMSystemasanon-invasiv...tCGM)systemanditsPrelude(TM)SkinPrepSystemfortrans...ey,M.D.,ChairmanandChiefExecutiveOfficer,willprese...sConference,sponsoredbytheNewYorkSocietyofSecuriti...
(Date:11/24/2009)...LYWOOD,Calif.,Nov.24/PRNewswire-FirstCall/--IPCThe...ionalhospitalistphysiciangrouppracticecompany,anno...list,wasnamedby ACPHospitalist asoneofthe2009TopTe...ber2009issueofthemagazine. ,, Dr.Vaidyanhasbeen...servesasdirectorofhospitalmedicineatSt.Mary,sHealt...
(Date:11/24/2009)...J.,Nov.24/PRNewswire/--MAQUETCardiovascularLLC,ale...dtodaythatithassignedaguaranteedtwo-yearcontractwi...rganizations,tobethesolesourceproviderofsurgicalde...termsoftheagreement,whichrunsthroughOctober31,2012...eatingheartdevicesanddisposablesuppliestothemember...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 1MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 2MapHIV org Shows 18 25 of Georgias Counties are Seriously Impacted by HIV 49642 3Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 1Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 49639 2Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 1Crown Consumer Brands Re Launches DentaBurst 28TM 29 Freshening Teeth Cleaners 49636 2
...t happens when leading,biochemists get together to...ften, incredible new drug therapies are born. Rece...or pharma scientists challenged the concept behind...ease that impacts millions,of Americans. They saw ...e,edema and weight gain, and went to work on a hyp...
...rmaceuticals, Inc. (OTC Bulletin Board: NURX) toda...ase I clinical trial of the first-in-class,rexinoi...ter study, which NuRx expects to complete in the f...e the safety and tolerability,of the compound. NRX...ical,trials., "Our preclinical data show that NRX...
Other Medicine Technology:NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2
(Date:11/25/2009)...ugh Sunday, November 29th, PlushBeds.com will be o...bed mattress + an additional 10% site-wide discoun...uarantee. Use the code “BLACKFRIDAY” i...ial offer. , (PRWEB) Nove... from Thanksgiving through the New Year to share h...
(Date:11/25/2009)...a board-certified plastic surgeon in Richmond , i...ernet technology to educate visitors on breast enh... new site incorporates a variety of media platform...uo;s designed to be an informative and user-friend... (Vocus) November 25, 2009...
(Date:11/25/2009)...uo;s Global Intention Heals Project proved that se... someone at a distance. Over 10,000 participants s...nteer who was monitored by a quantitative-EEG. The... Canada. , Vancouver, BC ...uo;s Global Intention Heals Project proved that s...
(Date:11/25/2009)...again commits to SAS70 Audit to demonstrate SOX an...WEB) November 25, 2009 -- Partners Consulting Serv...ion has completed the American Institute of Certif...g Standards (SAS) No. 70 type II audit. SAS 70 is ... the internal controls of service providers and ot...
(Date:11/25/2009)...mize your Emergency Department,s management of sea... season? Should you test all patients with flu-li...any - antiviral should you prescribe? EB Medicine ...icine Practice, which presents the very latest evi...agnosis and treatment. , ...
Breaking Medicine News(10 mins):Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:Partners Consulting Completes SAS70 Audit 2Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 2Health News:Emergency Medicine Practice Publishes 'Influenza: Challenges in Diagnosis and Management in the Emergency Department' 3
...t the accurate amount of fat in a human body, acco...ered as the standard for measuring the amount of f...dual's body weight divided by the square of their ...o be at a greater risk of heart disease, diabetes ...
...ctive pain reliever for children suffering severe ...phen// and codeine. Details of the study are publi...cs. Nearly 336 children aged from 6 to 17 sou...tawa. The children were randomly administered oral...
... a protein produced by the human genitalia may hav...nsmission can be brought under control by augmenti...ducted by Teunis Geijtenbeek and his team at Vrije...ns cells which form a web like network in skin and...
...r diseases in Latin Americans were outlined in a r...obesity, high cholesterol level and smoking. This ... Fernando Lanas, from the Universidad de la Fronte...ation for this study. This appears to be the large...
...omat who died due to Spanish flu in 1919 is likely...ientific community believes that there could be a ...h flu and the present H5N1 virus. If a link is...a professor of Virology at the Royal London Hospit...
... measles-mumps-rubella and varicella, or chicken p...nfants also even though their immune systems are n...sumption has always been that it would be OK, that...rics at the University of Rochester Medical Center...
Other Medicine News:Health News:Vaccines Effective in Preterm Babies too 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: